TUESDAY, June 29, 2021 (HealthDay News) — Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure. “There are many different types of amyloidosis,” explained study author Dr. Julian Gillmore, aContinue Reading

MONDAY, June 7, 2021 (HealthDay News) — Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds. “We were certainly disappointed in the results,” said study co-author Dr. Imre Noth, chief of pulmonary andContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage inContinue Reading

WEDNESDAY, June 2, 2021 (HealthDay News) — A new form of amyotrophic lateral sclerosis (ALS) that affects children has been discovered by an international team of researchers. They used advanced genetic techniques to identify 11 such cases in children who had mysterious neurological disorders. Most cases of ALS — alsoContinue Reading

TUESDAY, May 25, 2021 (HealthDay News) — The virus fueling the COVID-19 pandemic could become just an ordinary sniffle-causing nuisance within the next 10 years, a new study suggests. Researchers stressed that the projection is based on mathematical models, and not a crystal-ball prediction. But, they say, given what’s knownContinue Reading